๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

I04 Stem cell transplantation in multiple myeloma

โœ Scribed by G. Gahrton

Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
59 KB
Volume
21
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The role of stem cell transplantation in
The role of stem cell transplantation in multiple myeloma
โœ Jean-Luc Harousseau; Michel Attal ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 193 KB

High-dose therapy with autologous stem cell transplantation (ASCT) has been extensively used in the past 15 years in multiple myeloma. The IFM 90 trial has shown that autologous bone marrow transplantation (BMT) is superior to conventional chemotherapy in terms of response rate, event free survival,

Symptom burden after autologous stem cel
Symptom burden after autologous stem cell transplantation for multiple myeloma
โœ Erica Campagnaro; Rima Saliba; Sergio Giralt; Linda Roden; Floralyn Mendoza; Ana ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB

## Abstract ## BACKGROUND Multiple myeloma (MM) is the most common indication for highโ€dose chemotherapy with autologous stem cell transplantation (ASCT) in the U.S. and can be associated with substantial morbidity. Thorough assessment and understanding of symptoms and risk factors for symptom dev

Busulfan, cyclophosphamide, and etoposid
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
โœ Christopher R. Cogle; Jan S. Moreb; Helen L. Leather; Katarzyna J. Finiewicz; Sh ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 2 views

## Abstract Autologous stem cell transplantation (ASCT) has enabled the use of highโ€dose alkylating agents either as a single agent or in combination with other cytotoxic agents and/or total body irradiation (TBI) for the treatment of multiple myeloma. Despite improved complete remission rates, rel